Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease: Prospective, Randomized, Controlled Study.
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2013
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Jun 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.